133 related articles for article (PubMed ID: 6221935)
1. T cell-mediated cytolysis: on the strength of effector-target cell interaction.
Bongrand P; Pierres M; Golstein P
Eur J Immunol; 1983 May; 13(5):424-9. PubMed ID: 6221935
[TBL] [Abstract][Full Text] [Related]
2. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
Hiserodt JC
J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage.
Vargas-Cortes M; Hammarström ML; Hammarström S; Hellström U; Perlmann P
Eur J Immunol; 1986 Jul; 16(7):795-801. PubMed ID: 3522246
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of murine T cell-mediated cytolysis and T cell proliferation by a rat monoclonal antibody immunoprecipitating two lymphoid cell surface polypeptides of 94 000 and 180 000 molecular weight.
Pierres M; Goridis C; Golstein P
Eur J Immunol; 1982 Jan; 12(1):60-9. PubMed ID: 6977452
[TBL] [Abstract][Full Text] [Related]
5. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
Bolhuis RL; Roozemond RC; van de Griend RJ
J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
[TBL] [Abstract][Full Text] [Related]
6. Human cytotoxic T cell structures associated with expression of cytolysis. I. Analysis at the clonal cell level of the cytolysis-inhibiting effect of 7 monoclonal antibodies.
Malissen B; Rebai N; Liabeuf A; Mawas C
Eur J Immunol; 1982 Sep; 12(9):739-47. PubMed ID: 6982820
[TBL] [Abstract][Full Text] [Related]
7. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
[TBL] [Abstract][Full Text] [Related]
8. T lymphocyte-mediated cytolysis: dissociation of the binding and lytic mechanisms of the effector cell.
Fishelson Z; Berke G
J Immunol; 1978 Apr; 120(4):1121-6. PubMed ID: 305932
[TBL] [Abstract][Full Text] [Related]
9. Human T cell antigens involved in cytotoxicity against allogeneic or autologous chemically modified targets. Association of the Leu 2a/T8 antigen with effector-target cell binding and of the T3/Leu 4 antigen with triggering.
Platsoucas CD
Eur J Immunol; 1984 Jun; 14(6):566-77. PubMed ID: 6610558
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of cell-mediated cytotoxicity at the single cell level. II. Evidence for first-order kinetics of T cell-mediated cytolysis and for heterogeneity of lytic rate.
Grimm EA; Thoma JA; Bonavida B
J Immunol; 1979 Dec; 123(6):2870-7. PubMed ID: 315433
[TBL] [Abstract][Full Text] [Related]
11. T lymphocyte-mediated cytolysis. I. A common mechanism for target recognition in specific and lectin-dependent cytolysis.
Berke G; Hu V; McVey E; Clark WR
J Immunol; 1981 Aug; 127(2):776-81. PubMed ID: 6972974
[TBL] [Abstract][Full Text] [Related]
12. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
Neville ME; Hiserodt JC
J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR.
van de Griend RJ; Bolhuis RL; Stoter G; Roozemond RC
J Immunol; 1987 May; 138(10):3137-44. PubMed ID: 2952709
[TBL] [Abstract][Full Text] [Related]
15. T lymphocyte-mediated cytolysis. II. Role of target cell histocompatibility antigens in recognition and lysis.
Berke G; McVey E; Hu V; Clark WR
J Immunol; 1981 Aug; 127(2):782-7. PubMed ID: 6265557
[TBL] [Abstract][Full Text] [Related]
16. Characterization of anti-CD8-resistant cytolytic T lymphocytes induced by multivalent cross-linking of CD8 on precursor cells.
McCarthy SA; Kaldjian E; Singer A
J Immunol; 1989 Oct; 143(7):2112-9. PubMed ID: 2528588
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways.
Karlhofer FM; Yokoyama WM
J Immunol; 1991 May; 146(10):3662-73. PubMed ID: 2026886
[TBL] [Abstract][Full Text] [Related]
18. Interactions of lectins and monoclonal antibodies with human mononuclear cells. I. Specific inhibition of OKT4 and OKT8 binding by Ricinus communis agglutinin and wheat germ agglutinin.
Boldt DH; Dorsey SA
J Immunol; 1983 Apr; 130(4):1646-53. PubMed ID: 6601134
[TBL] [Abstract][Full Text] [Related]
19. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
Lancki DW; Kaper BP; Fitch FW
J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047
[TBL] [Abstract][Full Text] [Related]
20. Cytolysis of leukemic B-cells by T-cells activated via two bispecific antibodies.
Bohlen H; Manzke O; Patel B; Moldenhauer G; Dörken B; von Fliedner V; Diehl V; Tesch H
Cancer Res; 1993 Sep; 53(18):4310-4. PubMed ID: 7689932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]